Related Experiment Videos
Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell
Shafie Fazel1, Liwen Chen, Richard D Weisel
1Division of Cardiac Surgery, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
The Journal of Thoracic and Cardiovascular Surgery
|November 1, 2005
Summary
Mesenchymal stem cell therapy after heart attack improves cardiac function by boosting natural repair mechanisms, enhanced by stem cell factor. This approach promotes healing without direct myocyte regeneration.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Biology
Background:
- Acute myocardial infarction (AMI) leads to significant cardiac damage and impaired function.
- Mesenchymal stem cells (MSCs) are being investigated for their therapeutic potential in cardiac repair.
- The stem cell factor (SCF) pathway is implicated in stem cell mobilization and function.
Purpose of the Study:
- To investigate if MSC implantation after AMI activates the SCF pathway to mobilize bone marrow precursor cells.
- To determine if overactivating the SCF pathway enhances the beneficial effects of MSC transplantation.
- To evaluate the impact of MSCs and SCF modulation on cardiac function and regeneration.
Main Methods:
- Adult MSCs or SCF-overproducing MSCs were injected into the left ventricle after coronary ligation in a mouse model.
- Tracking of injected cells was performed using beta-galactosidase transgenic mice.
- Cardiac function was assessed using pressure-volume loops, and ventricular morphometrics were measured.
- Cytokine levels, endothelial progenitor cells, and myocardial angiogenesis were evaluated.
Main Results:
- MSC implantation increased stem cell factor levels, endothelial progenitor cell mobilization, and myocardial angiogenesis.
- Cell transplantation improved cardiac function indices and reduced ventricular volumes and infarct scar size.
- SCF overproduction by MSCs led to greater functional benefits without inducing cardiomyocyte regeneration.
Conclusions:
- MSC implantation facilitates functional cardiac regeneration after myocardial infarction by augmenting endogenous repair.
- The stem cell factor pathway plays a crucial role in mediating the beneficial effects of MSCs post-MI.
- Enhancing the SCF pathway amplifies the therapeutic outcomes of MSC-based cardiac repair.